Disease | N. SNPs d | DSI v | DPI v | Chr | Position | Consequence | Alleles | Class | AFEXOME | AFGENOME | Score vda | EI vda | N. PMIDs | First Ref. | Last Ref. | ||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Malignant neoplasm of lung
|
1142 | 0.620 | 0.640 | 5 | 1321972 | intron variant | C/T | snv | 0.48 | 0.800 | 1.000 | 17 | 2008 | 2018 | |||||
Carcinoma of lung
|
1204 | 0.620 | 0.640 | 5 | 1321972 | intron variant | C/T | snv | 0.48 | 0.800 | 1.000 | 16 | 2008 | 2018 | |||||
Primary malignant neoplasm of lung
|
981 | 0.620 | 0.640 | 5 | 1321972 | intron variant | C/T | snv | 0.48 | 0.100 | 1.000 | 15 | 2009 | 2018 | |||||
Malignant Neoplasms
|
1641 | 0.620 | 0.640 | 5 | 1321972 | intron variant | C/T | snv | 0.48 | 0.100 | 1.000 | 11 | 2009 | 2017 | |||||
Primary malignant neoplasm
|
1374 | 0.620 | 0.640 | 5 | 1321972 | intron variant | C/T | snv | 0.48 | 0.090 | 1.000 | 9 | 2009 | 2017 | |||||
melanoma
|
515 | 0.620 | 0.640 | 5 | 1321972 | intron variant | C/T | snv | 0.48 | 0.860 | 1.000 | 7 | 2010 | 2015 | |||||
Pancreatic carcinoma
|
322 | 0.620 | 0.640 | 5 | 1321972 | intron variant | C/T | snv | 0.48 | 0.740 | 1.000 | 7 | 2010 | 2018 | |||||
Carcinoma, Basal Cell
|
91 | 0.620 | 0.640 | 5 | 1321972 | intron variant | C/T | snv | 0.48 | 0.740 | 1.000 | 6 | 2009 | 2017 | |||||
Malignant neoplasm of pancreas
|
277 | 0.620 | 0.640 | 5 | 1321972 | intron variant | C/T | snv | 0.48 | 0.740 | 1.000 | 5 | 2010 | 2015 | |||||
Neoplasms
|
1644 | 0.620 | 0.640 | 5 | 1321972 | intron variant | C/T | snv | 0.48 | 0.050 | 0.800 | 5 | 2014 | 2017 | |||||
Adenocarcinoma
|
168 | 0.620 | 0.640 | 5 | 1321972 | intron variant | C/T | snv | 0.48 | 0.040 | 1.000 | 4 | 2013 | 2016 | |||||
Cleft palate with cleft lip
|
43 | 0.620 | 0.640 | 5 | 1321972 | intron variant | C/T | snv | 0.48 | 0.040 | 1.000 | 4 | 2013 | 2017 | |||||
Non-Small Cell Lung Carcinoma
|
712 | 0.620 | 0.640 | 5 | 1321972 | intron variant | C/T | snv | 0.48 | 0.730 | 0.750 | 4 | 2013 | 2019 | |||||
Adenocarcinoma of lung (disorder)
|
563 | 0.620 | 0.640 | 5 | 1321972 | intron variant | C/T | snv | 0.48 | 0.810 | 1.000 | 3 | 2009 | 2019 | |||||
Basal Cell Cancer
|
109 | 0.620 | 0.640 | 5 | 1321972 | intron variant | C/T | snv | 0.48 | 0.700 | 1.000 | 3 | 2009 | 2015 | |||||
Basal cell carcinoma
|
109 | 0.620 | 0.640 | 5 | 1321972 | intron variant | C/T | snv | 0.48 | 0.700 | 1.000 | 3 | 2009 | 2015 | |||||
Basal Cell Neoplasm
|
109 | 0.620 | 0.640 | 5 | 1321972 | intron variant | C/T | snv | 0.48 | 0.700 | 1.000 | 3 | 2009 | 2015 | |||||
Carcinoma of bladder
|
309 | 0.620 | 0.640 | 5 | 1321972 | intron variant | C/T | snv | 0.48 | 0.710 | 0.667 | 3 | 2010 | 2014 | |||||
Experimental Organism Basal Cell Carcinoma
|
63 | 0.620 | 0.640 | 5 | 1321972 | intron variant | C/T | snv | 0.48 | 0.030 | 1.000 | 3 | 2011 | 2017 | |||||
Malignant neoplasm of urinary bladder
|
316 | 0.620 | 0.640 | 5 | 1321972 | intron variant | C/T | snv | 0.48 | 0.710 | 0.667 | 3 | 2010 | 2014 | |||||
Nasopharyngeal carcinoma
|
320 | 0.620 | 0.640 | 5 | 1321972 | intron variant | C/T | snv | 0.48 | 0.720 | 1.000 | 3 | 2010 | 2016 | |||||
Squamous cell carcinoma
|
257 | 0.620 | 0.640 | 5 | 1321972 | intron variant | C/T | snv | 0.48 | 0.030 | 1.000 | 3 | 2011 | 2014 | |||||
Liver carcinoma
|
942 | 0.620 | 0.640 | 5 | 1321972 | intron variant | C/T | snv | 0.48 | 0.020 | 1.000 | 2 | 2014 | 2017 | |||||
Small cell carcinoma of lung
|
125 | 0.620 | 0.640 | 5 | 1321972 | intron variant | C/T | snv | 0.48 | 0.020 | 0.500 | 2 | 2013 | 2014 | |||||
Squamous cell carcinoma of esophagus
|
329 | 0.620 | 0.640 | 5 | 1321972 | intron variant | C/T | snv | 0.48 | 0.020 | 0.500 | 2 | 2013 | 2014 |